Skip to main
LFST

LFST Stock Forecast & Price Target

LFST Analyst Ratings

Based on 7 analyst ratings
Buy
Strong Buy 43%
Buy 43%
Hold 14%
Sell 0%
Strong Sell 0%

Bulls say

LifeStance Health Gr is a financially stable company with strong growth potential in the mental health industry. With a high demand for mental health services, their large group of clinicians and partnerships with health systems and plans give them a competitive advantage. Their successful initiatives, selective recruitment of doctors, and strong referral network position them for continued mid-teens growth and high clinician retention. Their dedication to quality and accessible care, along with positive feedback from investors and a strong understanding of health plans' needs, make them a favorable investment opportunity.

Bears say

LifeStance Health Gr is a mental healthcare company that operates using evidence-based approaches to treat a broad range of mental health conditions. However, its lack of profitability and exposure to government payers, combined with the increasing prevalence of mental health conditions and competition from other mental health support companies, lead to a negative outlook on its stock. Additionally, its high valuation compared to other players in the industry also contributes to the negative outlook.

LFST has been analyzed by 7 analysts, with a consensus rating of Buy. 43% of analysts recommend a Strong Buy, 43% recommend Buy, 14% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of LifeStance Health Group and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About LifeStance Health Group (LFST) Forecast

Analysts have given LFST a Buy based on their latest research and market trends.

According to 7 analysts, LFST has a Buy consensus rating as of May 19, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $9.86, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $9.86, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

LifeStance Health Group (LFST)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.